Applied DNA Sciences Inc. announced the formation of a Strategic Advisory Board (SAB) that will provide guidance and industry outreach in specific market verticals. Bob Catell, Chairman New York State Smart Grid Consortium, Chairman, U.S., Advanced Energy Research and Technology Center at Stony Brook, Former Chairman of National Grid U.S., and former Chairman and CEO of KeySpan Corporation. Bob will guide the strategies for railways and power authorities across the globe.

A His impressive leadership abilities and worldwide perspective, will provide with industry knowledge and a lens to forward thinking concepts which will optimize its solutions in these two emerging markets for APDN. Mr. Catell has agreed to Chair the Strategic Advisory Board. Gunther Faber, former Vice President, Sub-Saharan Africa, for GlaxoSmithKline, has more than 30 years of experience working in the pharmaceutical industry.

Gunther was also a member of the company's Policy Team on Access to Medicine. Gunther is currently the Chairman and Chief Executive Officer of One Family Health. Gunther's experience working in Africa, which has a high concentration of pharmaceutical counterfeits, will provide critical perspective to educate leaders and create industry awareness linking its solutions to prevent the pharmaceutical supply chain from being compromised.

Bob Miglani, serves as Senior Director, External Medical Affairs for Pfizer Inc., in New York City. Bob has been with Pfizer for 23 years, developing innovative partnerships with medical and healthcare organizations in the US and around the world in the area of health and wellness, new customer partnerships and public health. Bob's domain knowledge in the pharmaceutical sector will be invaluable as it expand its solutions into this vertical to combat the increasing counterfeiting issue that is threatening hundreds of thousands of lives a year across the globe.